國家衛生研究院 NHRI:Items for Author

Year

Loading year class tree, please wait....

Items for Author "Lee, KH"

Return to Browse by Author

Showing 38 items.

Collection	Date	Title	Relation
[其他] 期刊論文	2024-02	Advantages of retrograde intrarenal incision versus laparoscopic surgery in management of pararenal cysts: A single-center experience	-
[其他] 期刊論文	2020-12	Puralpha regulates the induction of Znf179 transcription during neuronal differentiation	-
[張俊彥] 期刊論文	2000-03-01	Unique biochemical, cytotoxic, and antitumor activity of camptothecin and 4 beta-amino-4'-O-demethylepipodophyllotoxin conjugates	-
[李秀珠] 期刊論文	2004-03	Cytotoxic and anti-HIV principles from the rhizomes of Begonia nantoensis	-
[楊重熙] 期刊論文	2015-01	Gold nanoparticles: BSA (Bovine Serum Albumin) coating and X-ray irradiation produce variable-spectrum photoluminescence	-
[楊重熙] 期刊論文	2010-07	Synchrotron microangiography studies of angiogenesis in mice with microemulsions and gold nanoparticles	-
[楊重熙] 期刊論文	2008-10-07	Optimizing the size and surface properties of polyethylene glycol (PEG)-gold nanoparticles by intense x-ray irradiation	-
[楊重熙] 期刊論文	2008-07-23	Enhanced x-ray irradiation-induced cancer cell damage by gold nanoparticles treated by a new synthesis method of polyethylene glycol modification	-
[潘秀玲(2009-2013)] 期刊論文	2012-07	DYZ-2-90, a novel neo-tanshinlactone ring-opened compound, induces ERK-mediated mitotic arrest and subsequent apoptosis by activating JNK in human colorectal cancer cells	-
[潘秀玲(2009-2013)] 期刊論文	2012-02	Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3beta and mTOR signaling pathways	-
[潘秀玲(2009-2013)] 期刊論文	2012-01	QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells	-
[蘇益仁(2002-2015)] 期刊論文	2012-07	Endoplasmic reticulum stress stimulates p53 expression through NF-kappaB activation	-
[蘇益仁(2002-2015)] 期刊論文	2011-12	Induction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cells	-
[許志成] 期刊論文	2017-05	Association of warfarin with congestive heart failure and peripheral artery occlusive disease in hemodialysis patients with atrial fibrillation	-
[許志成] 期刊論文	2016-02	Kidney disease progression in patients of upper tract urothelial carcinoma following unilateral radical nephroureterectomy	-
[許惠恒] 期刊論文	2023-03-10	Prediction of the risk of developing end-stage renal diseases in newly diagnosed type 2 diabetes mellitus using artificial intelligence algorithms	-
[謝興邦] 會議論文/會議摘要	2017-04	One-pot tandem oxidative dearomatization/ 4+3 cycloaddition: Masked o-benzoquinone with diaza-oxyallyl cation	-
[謝興邦] 期刊論文	2021-10-14	Discovery of BPR1R024, an orally active and selective CSF1R inhibitor that exhibits antitumor and immunomodulatory activity in a murine colon tumor model	-
[邱英明] 期刊論文	2010-04	The signals of FGFs on the neurogenesis of embryonic stem cells	-
[陳立宗] 會議論文/會議摘要	2018-11	Liposomal irinotecan (nal-IRI) plus 5-FU/LV in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) progressing on gemcitabine-based treatment: Further subgroup analyses of the pivotal NAPOLI-1 study	-
[陳立宗] 會議論文/會議摘要	2018-10	NAPOLI-1 phase III trial outcomes by prior surgery, and disease stage, in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)	-
[陳立宗] 會議論文/會議摘要	2018-02	Subgroup analysis by baseline (BL) weight-associated parameters: A phase III study of liposomal irinotecan (nal-IRI)+/--5fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with g	-
[陳立宗] 會議論文/會議摘要	2017-11	Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI65-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy	-
[陳立宗] 會議論文/會議摘要	2017-09	Prognostic value of baseline neutrophil-to-lymphocyte ratio for predicting clinical outcome in metastatic pancreatic ductal adenocarcinoma (mPDAC) patients treated with liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alon	-
[陳立宗] 會議論文/會議摘要	2017-05	The prognostic value of baseline neutrophilto-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for predicting clinical outcome in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan (nal-IRI; MM	-
[陳立宗] 會議論文/會議摘要	2017-02	Characteristics of long-term survivors in a randomized phase III trial (NAPOLI-1) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan (nal-IRI; MM-398)+5-FU/LV	-
[陳立宗] 會議論文/會議摘要	2016-12	Efficacy and safety of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02, BAX-2398) in patients with metastatic pancreatic cancer in Asia: A subgroup analysis of the phase 3 NAPOLI-1 Study	-
[陳立宗] 會議論文/會議摘要	2016-10	Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	-
[陳立宗] 會議論文/會議摘要	2016-10	Time course of selected treatment emergent adverse events (TEAEs) in NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based ther	-
[陳立宗] 會議論文/會議摘要	2016-05	Updated overall survival (OS) analysis of NAPOLI-1: Phase 3 study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine	-
[陳立宗] 會議論文/會議摘要	2016-02	Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	-
[陳立宗] 會議論文/會議摘要	2016-02	Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	-
[陳立宗] 會議論文/會議摘要	2015-01	Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	-
[陳立宗] 期刊論文	2020-02	Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study	-
[陳立宗] 期刊論文	2020-01	Liposomal irinotecan + 5-FU/LV in metastatic pancreatic cancer: Subgroup analyses of patient, tumor, and previous treatment characteristics in the pivotal NAPOLI-1 trial	-
[陳立宗] 期刊論文	2018-11-07	Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial	-
[陳立宗] 期刊論文	2016-02	Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial	-
[陳麗光] 期刊論文	2018-09-12	Norepinephrine administration is associated with higher mortality in dialysis requiring acute kidney injury patients with septic shock	-

Loading...

Category

Year

Items for Author "Lee, KH"